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ABSTRACT
The XPA (Xeroderma pigmentosum A) protein is one
of the six core factors of the human nucleotide
excision repair system. In this study we show that
XPA is a rate-limiting factor in all human cell lines
tested, including a normal human fibroblast cell
line. The level of XPA is controlled at the transcrip-
tional level by the molecular circadian clock and at
the post-translational level by a HECT domain family
E3 ubiquitin ligase called HERC2. Stabilization
of XPA by downregulation of HERC2 moderately
enhances excision repair activity. Conversely, down-
regulation of XPA by siRNA reduces excision
repair activity in proportion to the level of XPA.
Ubiquitination and proteolysis of XPA are inhibited
by DNA damage that promotes tight association
of the protein with chromatin and its dissociation
from the HERC2 E3 ligase. Finally, in agreement
with a recent report, we find that XPA is post-
translationally modified by acetylation. However,
contrary to the previous claim, we find that in
mouse liver only a small fraction of XPA is acetylated
and that downregulation of SIRT1 deacetylase in two
human cell lines does not affect the overall repair
rate. Collectively, the data reveal that XPA is a
limiting factor in excision repair and that its level is
coordinately regulated by the circadian clock, the
ubiquitin–proteasome system and DNA damage.
INTRODUCTION
Nucleotide excision repair (excision repair) is the primary
repair system for removing bulky base adducts from DNA
in organisms ranging from Escherichia coli to humans
(1–4). The repair system has a wide substrate spectrum,
ranging from lesions such as thymine glycols that cause
a modest helical distortion to the benzo[a]pyrene-guanine
adducts that induce major changes in DNA structures.
Intrinsic to such a repair system of low speciﬁcity is the
ability to process undamaged DNA at a low but ﬁnite
rate. Indeed, it has been found that both human and bac-
terial excision repair systems attack undamaged DNA at a
measurable rate (5) and excise undamaged DNA frag-
ments leading to gratuitous excision and repair synthesis.
This gratuitous DNA repair may result in spontaneous
mutagenesis (6,7) with undesirable consequences. Thus,
from an evolutionary perspective, it would be beneﬁcial
if the levels of repair factors were under tight regulation
such that repair activity increased at times of genotoxic
stress or times of potential genotoxic stress and were
downregulated when the damage is eliminated or the
probability of damage occurring is relatively low.
Indeed, in prokaryotes the levels of excision repair
proteins UvrA and UvrB, which are involved in damage
recognition, are tightly controlled by the SOS response
system and the ClpXP protease: the levels of UvrA and
UvrB increase in response to DNA damage by SOS-
mediated transcriptional upregulation and, upon elimin-
ation of DNA damage, the transcription of the SOS genes
including UvrA and UvrB is turned off and the
accumulated UvrA and possibly UvrB are degraded by
ClpXP protease (8,9).
Inmammaliancells,DNAdamageexcisioniscarriedout
by six repair factors comprising 16 polypeptides, RPA,
XPA, XPC, TFIIH, XPG and XPF ERCC1 (1,2).
Additionally, DDB2 (the XPE gene product) in complex
with DDB1, UV-DDB, may stimulate excision repair (10).
There is no known SOS response in mammalian cells
in terms of coordinated transcriptional response to UV
and UV-mimetic agents that promotes cell survival by
upregulating excision-, recombination- and post-
replication repair/recovery pathways. Instead, there is a
frequently discussed, but mechanistically ill-deﬁned,
system involving transcriptional induction and post-
translational ubiquitination of XPC and DDB2. In short,
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transcription is induced by UV and that both proteins are
subject to regulation by proteolysis, there is no convincing
evidence that DDB2 (in the form of UV-DDB) plays
any direct role in excision repair or that transcriptional
induction and ubiquitination of XPC affect the level or
activity of the protein (10–12). In contrast to DDB2,
which may or may not play a role in repair and XPC that
is required for transcription independent but not for
transcription-coupled repair, XPA is an essential compo-
nent of both pathways for excision repair and its transcrip-
tional and post-transcriptional regulation may have
signiﬁcant effects on cellular repair and survival following
exposure to UV and UV-mimetic agents.
Recently, we reported that excision repair in mice is
regulated by the circadian clock such that the repair
activity changed by  10-fold over the course of the day
(13,14). We reported that this oscillation was accom-
plished by transcriptional control of the XPA gene by
the core clock transcription–translation feedback loop
and presented preliminary data that the putative mamma-
lian HERC2 E3 ligase contributed to the robust high amp-
litude oscillatory pattern of XPA and hence of excision
repair. In this article, we expand on the previous
ﬁndings to demonstrate that the XPA level is rate
limiting in vivo in normal human ﬁbroblasts and that
manipulating XPA levels by gene knockdown of XPA or
HERC2 using siRNA affects the rate of excision repair
in vivo. We further show that the HECT domain of
HERC2 is necessary and sufﬁcient for ubiquitination of
XPA. Finally, we show that XPA is subject to acetylation
in mouse liver but that only a small percent of XPA is
acetylated and the acetylation pattern does not correlate
with excision repair activity. Furthermore,
downregulation of NAD
+-dependent SIRT1 deacetylase
in two human cell lines has no measurable effect on the
overall rate of repair by human excision nuclease. Taken
together, our data indicate that XPA and hence excision
repair in mammals is regulated by the circadian clock at
the transcriptional level and by HERC2 ubiquitin ligase at
the post-translational level.
MATERIALS AND METHODS
Cell culture and siRNA transfection
HEK293T, A549, HeLa (obtained from ATCC), NHF-1(15)
and XP-A (XP2OS) cell lines [Coriell Institute, (16)] were
grown in Dulbecco’s Modiﬁed Eagle Medium (DMEM,
Gibco) supplemented with 10% fetal bovine serum and
100U/ml penicillin G and 0.1mg/ml streptomycin. For
the analysis of protein stability, cells were treated with
20mg/ml cycloheximide (Sigma) for the indicated times.
DharmaFECT reagent (Dharmacon) was used according
to the manufacturer’s directions for transfection of ON-
TARGET plus SMARTpool siRNA duplexes obtained
from Dharmacon [XPA (L-005067-00-0050), HERC1
(L-007181-00-0005), HERC2 (L-007180-00-0020), RNF8
(L-006900-00-0005) or Cyclophilin B (D-001820-01-20) as a
control]. siRNA (100nM) was used for transfection unless
otherwise indicated.
UV-damage repair assay
Cells grown in 12-well plates to near conﬂuency were
washed once with pre-warmed Hank’s balanced salt
solution (Gibco) prior to UV irradiation at the indicated
J/m
2 from a germicidal lamp (GE) emitting primarily
UV-C light. After UV irradiation, culture media was
added back to the cells and repair was allowed for the
indicated times before harvesting. Genomic DNA prepar-
ation and transfer to membranes were described in a
previous report (14). Cyclobutane thymine dimer (CPD)
and 6–4 photoproduct [(6–4)PP] UV damages were
detected by immunoslot blot using anti-CPD (Kamiya)
and anti-(6–4)PP (Cosmo Bio) monoclonal antibodies,
respectively. After the immunoslot blot assay, total
DNA amounts loaded onto the membrane were visualized
by Sybr-gold staining, and these values were used to
normalize the values.
Immunoblotting
Protein levels from whole cell lysates or fractionated extracts
were determined by immunoblot assay. Antibodies used
in this study include XPA (Kamiya), XPF and RNF8
(Abcam), GAPDH (Cell Signaling Technology),
C y c l o p h i l i nBa n dP C N A( S a nta Cruz Biotechnology),
HERC1 and HERC2 (Bethyl Laboratory), Flag (Sigma),
histone H2AX, H3, SIRT1 and Acetyl-lysine (Millipore)
and Cry1 (17).
RT–PCR
Total RNA preparation and reverse transcription were
done as described previously (18). The following primers
were used for PCR (for RNF8 50: CTACCTCTAGGCAT
GTTTCA and 30: ATTGTGACCAATGGCAGATC; for
HERC2 50: CTGCCCTTCACAGTGCCAAG and 30:G G
TCTGGAGGGTTGTATTTA; for XPA 50 CAGCCCCA
AAGATAATTGAC and 30: CGCTGCTTCTTACTGCT
CGC; and for  -ACTIN 50 GTTCCGATGCCCTGAGG
CTC and 30: CACTTGCGGTGCACGATGGA).
Recombinant protein puriﬁcation
Flag-tagged XPA and HECT domain of HERC2 (wild-type
and Cys!Ala mutant) were immunopuriﬁed using
anti-Flag agarose (Sigma). Flag-XPA was prepared as
reported previously (14). Human HECT domain of
HERC2 was ampliﬁed by RT–PCR and subcloned into a
Topo-TA vector (Invitrogen). This DNA was used as PCR
template to introduce appropriate restriction sites and Flag
and 6X His epitope tags at the 50-a n d3 0-ends, respectively,
and subcloned into the pcDNA3 vector. The C4762A
mutation at the active site was introduced by site-directed
mutagenesis (Stratagene QuikChange). DNA constructs
were sequenced prior to use. The HECT domain of
HERC2 was transiently expressed in HEK293T cells using
Lipofectamine 2000 reagent (Invitrogen). After 24h cells
w e r eh a r v e s t e da n dl y s e dw i t hT B Sb u f f e r( 5 0 m MT r i s –
HCl pH 7.5, 150mM NaCl) containing 0.5% NP-40, and
puriﬁed with anti-Flag-agarose. After extensive washing
with TBS buffer, the bound proteins were eluted with TBS
buffer containing 0.3mg/ml Flag-peptide (Sigma).
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Either immunoprecipitated-HERC2 from HEK293T
whole cell lysate (Figure 3C) or puriﬁed HECT domain
of HERC2 (Figure 3D) was used in the ubiquitination
assay with Flag-XPA puriﬁed from HEK293T cells as
the substrate. Brieﬂy 1.5ng of E1 (UBE1), 10ng of E2
(UbcH5a), 500ng of HA-ubiquitin and 500ng of
puriﬁed Flag-XPA were incubated in a buffer containing
50mM Tris pH 7.6, 5mM MgCl2, 0.6mM DTT and
2mM ATP for 30min at 30 C. Ubiquitinated-XPA was
detected by immunoblot assay using either anti-Flag
or anti-XPA antibody. Recombinant UBE1, GST-
UbcH5a and HA-ubiquitin were purchased from Boston
Biochem.
Mouse liver extracts
Cry1
 / Cry2
 /  mice in C57BL/6J background were
generated in our laboratory (17,19), and wild-type
control animals (10-weeks-old C57BL/6J male mice)
were purchased from the Jackson Laboratory (Bar
Harbor, ME). Mice were maintained on a light/dark
12:12 schedule for at least 2 weeks before sacriﬁce. ZT0
is the time of light-on and ZT12 is the time of light-off.
The mice were handled in accordance with the guidelines
of the NIH and the University of North Carolina School
of Medicine. At the indicated times, the mice were
sacriﬁced by carbon dioxide exposure, liver tissues were
removed, washed extensively with cold phosphate
buffered saline (PBS), diced into <1mm
3 pieces and
incubated with red blood cell lysing buffer (Sigma) for
5min at 30 C. The liver tissues were homogenized in
hypotonic cytosol extraction buffer [10mM HEPES
(pH 7.6), 40mM KCl, 3mM MgCl2, 2mM DTT, 5%
glycerol (vol/vol), 0.5% NP-40 and protease inhibitor
cocktail (Roche)]. After centrifugation (1250g) for 5min
at 4 C, supernatant (cytosol extract) was removed and
nuclei were washed extensively with cytosol buffer and
then extracted with high salt nuclear extraction buffer
[10 mM HEPES (pH 7.9), 450mM NaCl, 1.5mM
MgCl2, 0.1mM EGTA, 0.5mM DTT, 25% glycerol
(vol/vol) and protease inhibitor cocktail] to obtain
soluble fraction (nuclear extract).
XPA acetylation levels in mouse liver tissue
Total acetylated proteins from liver extracts were
immunoprecipitated with an anti-acetyl lysine antibody,
and acetylated-XPA was detected by immunoblotting
with anti-XPA antibody. For second immunopre-
cipitation (2  IP) analysis (Figure 5D), lysates from the
ﬁrst immunoprecipitation (1  IP) were subjected to a
second round of precipitation to ensure that all acetylated
XPA was identiﬁed.
RESULTS
XPA is rate limiting in excision repair in human cell lines
Previously, we reported that excision repair in mouse
brain and liver extracts harvested at various times of the
day exhibited a circadian rhythmicity with the minimum
around the biological dawn and the maximum at the bio-
logical dusk. To determine the cause of this oscillatory
pattern, we analyzed the expression proﬁles of the six
core excision repair factors to determine which were re-
sponsible for the cyclic change in repair activity. We found
that XPA exhibited a circadian pattern of expression with
a maximum at the biological dusk and a minimum at bio-
logical dawn both at the mRNA and the protein levels. In
contrast, the transcript and the protein levels of the poly-
peptides of all other ﬁve core excision repair factors and
the excision repair accessory protein XPE (DDB2)
remained essentially constant over the course of the day.
Thus, we ascribed the circadian rhythmicity of excision
repair activity to the oscillatory pattern of XPA protein
level. In support of this interpretation, we found that low
excision repair activity in extracts of tissues harvested in
the early morning hours could be complemented with
puriﬁed XPA protein (13).
However, it has been reported that in a human cell line
expressing XPA under control of the tetracycline on/off
system there was no correlation between the XPA level in
the cell and the excision repair activity, leading to the
conclusion that XPA is not rate limiting for excision
repair in human cells (20). Hence, we decided to
downregulate XPA by siRNA in various human cell
lines and test them for excision repair activity in vivo.
The results obtained with a non-transformed cell line
NHF-1 (TERT-immortalized normal human ﬁbroblast),
a lung cancer cell line with a functional p53 (A549) and
a cervical cancer cell line with non-functional p53 (HeLa)
are shown in Figure 1. The A549 and HeLa cells, p53 (+)
and p53 (–), respectively, were chosen because it has been
reported that p53 affects excision repair by an ill-deﬁned
mechanism (21,22) and therefore we wished to test the
repair rate in both backgrounds, and we chose NHF-1
as representative of normal mammalian tissues. As is
apparent from Figure 1A the two cancer cell lines
express XPA at considerably higher levels than the
normal human ﬁbroblasts. As a consequence, even after
downregulation by siRNA, these cell lines contain XPA
(normalized to total protein) at a level comparable to that
in normal ﬁbroblasts before downregulation. These differ-
ences in the XPA levels are reﬂected in the repair kinetics
of the UV photoproducts (Figure 1B–E): Downregulation
of XPA to about 1/15th of its original level in NHF-1
abolished CPD repair and reduced the rate of (6–4)PP
repair by a factor of  2. Repair of the latter lesion is
only moderately affected because of its much higher
afﬁnity relative to CPD for XPA and the other damage
recognition factors, XPC and RPA (23). Proportionally
(but not in absolute terms) similar reductions in XPA
levels in A549 and HeLa cells have more modest, but stat-
istically signiﬁcant, effects on CPD repair and even less
pronounced (or in the case of HeLa no measurable effect)
on the rate of repair of (6–4)PP. It must be noted,
however, that these cancer cell lines are polyploid and
hence contain more DNA as well as more XPA per cell
and it is difﬁcult to deconvolute the opposing effects of
these two factors on the photoproduct density and repair
rates. Hence, we decided to conduct our studies regarding
the relationship between XPA level and excision repair
3178 Nucleic Acids Research, 2011,Vol.39, No. 8capacity on the NHF-1 cell line which approximates a
normal diploid human cell (15), and use other representa-
tive cell lines for the generality of our conclusions.
Proportionality of XPA levels with rate of excision repair
in normal human ﬁbroblasts
The data in Figure 1 show that drastic reduction in XPA
level in NHF-1 leads to a severe reduction in the rate of
repair of CPD. However, in mouse tissues, we observed a
more gradual change in XPA level over the course of the
day and a similarly gradual change in excision repair
activity (24). Therefore, we wished to examine the effect
of gradual changes in XPA level on the excision repair rate
in our model system. To this end, we downregulated the
XPA level in NHF-1 to varying degrees by using different
amounts of siRNA in transfection, then irradiated the
cells with UV and measured the rates of removal of UV
photoproducts. The results are shown in Figure 2. As
expected, varying the amounts of XPA siRNA resulted
in different levels of XPA depletion (Figure 2A) and the
reduction in XPA level proportionally affected the repair
of both CPD and the (6–4)PP as measured by slot–blot
assay (Figure 2B and C). Quantitative analyses of the slot–
blot data reveal that there is an approximately linear re-
lationship between the XPA level and the rate of repair of
CPDs (Figure 2E and G). The rate of repair of (6–4)PP
was only moderately affected when XPA was reduced to
60% of its original level but more severe changes in
NHF-1 XPA levels, such as those observed between the
zenith and nadir values of XPA in mouse tissues, resulted
in reduction in repair rates comparable to those seen with
CPDs (Figure 2D and F). These results are consistent with
the in vitro (25) and in vivo (23) data that (6–4)PP is a 5- to
10-fold more efﬁcient substrate for human excision
nuclease and its rate of repair is better buffered against
minor ﬂuctuations of the rate limiting repair factors.
Importantly, on the whole these data support the conclu-
sion that rhythmic changes in XPA levels in mouse brain
and liver are responsible for rhythmicity of excision repair
in these tissues.
Figure 1. Protein level of XPA is a determinant of the DNA excision repair activity. (A) Protein levels in human cells were analyzed by immuno-
blotting with the indicated antibodies from cells transfected with 100nM siRNA targeting XPA or cyclophylin B (Control, CTRL). (B and C)
Residual CPD (B) or (6–4)PP (C) damage in genomic DNA was detected by immunoslot blotting using damage speciﬁc monoclonal antibodies.
Genomic DNA was prepared from cells transfected with indicated siRNAs for 24h and repair was allowed for the indicated times. (D and E)
Averages and error bars (standard deviations) are shown for data from two independent biological experiments and two technical repeats from each
biological experiment.
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With few exceptions (26) for a protein to show robust
circadian oscillation, the gene encoding it must ﬁrst, be
transcribed with circadian rhythmicity and secondly, the
protein must have a relatively short lifetime; even if a gene
is transcribed with circadian rhythm it would not show
high amplitude oscillation if it is stable (26). We previously
reported that XPA transcription is controlled by the cir-
cadian clock and presented preliminary evidence that the
XPA protein binds to and is ubiquitinated by the putative
HERC2 ubiquitin ligase resulting in the degradation of
XPA by the ubiquitin–proteasome system and short
lifetime that contributes to rhythmicity (14). However,
a subsequent study reported that HERC2 (which is a
putative HECT domain E3 ligase) functions mainly as a
scaffold for the RNF8 enzyme, a RING Finger type E3
ligase, which carries out the actual ubiquitination of some
key proteins both in double-strand break repair (27) and
in nucleotide excision repair (28). Therefore, we ﬁrst
wished to determine whether the HERC2-dependent
ubiquitination of XPA observed in our previous study
was actually carried out by HERC2 or by RNF8 that
might have co-immunoprecipitated with HERC2 and,
second, to assess the functional consequences of this
ubiquitination. To this end, we carried out siRNA
knockdown of HERC2 and RNF8 and tested the effects
of these downregulations on XPA levels, XPA
ubiquitination and UV damage repair. The results are
shown in Figure 3. As seen in Figure 3A, both RNF8
and HERC2 are efﬁciently downregulated by the appro-
priate siRNAs. However, a strong cross-reacting
non-speciﬁc band in the RNF8 immunoblot raised some
concern regarding the efﬁcacy of the RNF8 siRNA.
Therefore, we tested the efﬁciency of this siRNA by
RT–PCR. As is clear in Figure 3B the RNF8 siRNA is
very effective in downregulating the transcript and pre-
sumably the RNF8 protein. Therefore, the effects of
siRNAs of HERC2 and RNF8 on XPA ubiquitination
are likely to reﬂect the direct effects of these E3 ligases
on XPA. Importantly, Figure 3C shows that neither
RNF8 knockdown nor the downregulation of the
HERC2-related HECT-domain protein, HERC1, affects
XPA ubiquitination. In contrast, downregulation of
HERC2 essentially eliminated XPA ubiquitination,
indicating that HERC2 is the E3 ligase for XPA.
To conﬁrm this conclusion we expressed the HECT
domain or the HECT domain containing the Cys!Ala
mutation in the putative active site cysteine of HERC2
in HEK293T cells and immunopuriﬁed both the
wild-type and the mutant forms. The puriﬁed proteins
were tested for E3 ligase activity using XPA as a substrate.
The results are shown in Figure 3D. As is clear from this
ﬁgure, the wild-type HERC2 HECT domain, but not the
mutant form, ubiquitinates XPA. Taken together the
in vivo downregulation and the in vitro ubiquitination
data lead us to conclude that HERC2 is the ubiquitin
ligase responsible for ubiquitination and proteolytic deg-
radation of XPA and, therefore, HERC2 contributes to
Figure 2. Correlation between the XPA level and DNA excision repair activity in human cells. (A) Protein levels in NHF-1 cells transfected with
different amounts of siRNA targeting XPA for 24h were analyzed by immunoblotting with the indicated antibodies. CPB, cyclophilin B. (B and C)
Residual (6–4)PP (B) or CPD (C) damage in genomic DNA was detected by immunoslot blotting using damage speciﬁc monoclonal antibodies. (D
and E) Average repair values and standard deviations are shown for data from three independent experiments for the (6–4)PP (D) and CPD (E). (F
and G) Initial repair rate for (6–4)PP (F) and CPD (G) were measured as a function of XPA protein level which was manipulated by knockdown of
XPA using siRNA. The initial rates were calculated from the linear range of the kinetic data in D and E.
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we wished to test the effect of HERC2 downregulation
on XPA level and excision repair. HERC2 was
downregulated by siRNA to  10% of its level in A549
cells and then the cells were irradiated with 10J/m
2 and
the repair kinetics of (6–4)PP and CPD were determined.
Representative images of the slot blots are shown in
Figure 3E and quantitative analysis of the data is pre-
sented in Figure 3F along with the levels of HERC2
and XPA in control and HERC2 siRNA treated cells
(Figure 3F, inset). As expected, downregulation of
HERC2 leads to elevation of the steady-state level of
XPA (Figure 3F, inset). In parallel with this increase in
the XPA level the rates of repair of both UV photoprod-
ucts are elevated (Figure 3F), albeit not proportionally to
the level of elevation of XPA. We conclude that XPA is a
rate-limiting factor in human excision nuclease repair and
that reducing the XPA level decreases the repair of DNA
damage (Figure 2) and likewise, that elevation of XPA
level above normal increases the rate of repair.
Effect of DNA damage on XPA–HERC2 interaction and
XPA stability
To perform its repair function XPA must associate with
damaged chromatin, so we asked whether UV damage
affects the XPA–HERC2 interaction and therefore the
stability of XPA. We used the A549 cell line for this
series of experiments because these cells have functional
p53, which is known to affect DNA repair by an ill-deﬁned
mechanism (21,22), and performing the experiments in a
wild-type p53 background eliminates complications
arising from the global effects of p53 mutation that
affect cell physiology but are not directly involved in
repair. To determine the effect of DNA damage on XPA
stability, cells were irradiated with UV and incubated with
protein synthesis inhibitor cycloheximide for various time
Figure 3. Regulation of DNA excision repair by HERC2 via XPA stability control. (A) Protein levels were analyzed by immunoblotting with the
indicated antibodies from A549 cells transfected with the indicated siRNAs for 96h. Asterisk in the RNF8 blot indicates non-speciﬁc (NS) signal.
CPB, cyclophilin B. (B) cDNA was prepared from cells transfected with the indicated siRNAs and was used for the ampliﬁcation of the indicated
genes using PCR. (C) HERC2 was immunoprecipitated from cells transfected with the indicated siRNAs and was used for the ubiquitination assay.
Human Flag-XPA puriﬁed from 293T cells was used as a substrate. Total and ubiquitinated XPA were detected by immunoblotting with the
anti-Flag antibody. The amount of HERC2 immunoprecipitated from each siRNA treated cell was analyzed by immunoblotting with the
anti-HERC2 antibody. Asterisk in the Flag blot indicates NS signal. (D) Wild-type (WT) and mutant (Mut) HECT domain of HERC2 were
transiently expressed in 293T cells, immuno-puriﬁed using Flag-agarose beads and used for the ubiquitination assay. Flag-XPA was used as a
substrate. Total and ubiquitinated XPA were detected by immunoblotting with the anti-XPA antibody. The amount of HECT immunoprecipitated
was analyzed by immunoblotting with anti-Flag antibody. (E) Residual (6–4)PP or CPD damage in the genomic DNA was detected by immunoslot
blotting using damage speciﬁc monoclonal antibodies. (F) Average values and standard deviations from three independent experiments are shown.
Protein levels were analyzed from cells transfected with siRNAs with the indicated antibodies (inset).
Nucleic Acids Research,2011, Vol.39, No. 8 3181periods and the levels of XPA and HERC2 were
determined by immunoblotting. As is apparent from
Figure 4A and B, and in agreement with previous
ﬁndings (14), in the absence of DNA damage XPA
decays with a half-life of 3–4h. After UV irradiation,
XPA is greatly stabilized, reaching a half-life of >12h.
Interestingly, HERC2 in the absence of DNA damage ex-
hibited decay kinetics similar to that of XPA and was also
stabilized by UV damage. It should be noted that, in
agreement with previous reports (11), UV does not
induce XPA transcription (Figure 4C) and hence the
increase in XPA level after UV and in the presence
of cycloheximide must be due to the stabilization of
XPA protein. To gain some insight into the mechanism
of XPA stabilization following UV damage, we analyzed
the subcellular localization of XPA before and after
DNA damage. All XPA, with and without DNA
damage, is known to be localized in the nucleus (29).
However, after DNA damage, XPA rapidly associates
with the chromatin fraction without a signiﬁcant change
in HERC2 distribution (Figure 4D), suggesting that the
DNA damage-promoted physical separation of XPA
and HERC2 contributes to the increased stability of
XPA following UV irradiation. This suggestion was
reinforced by analyzing the XPA–HERC2 interaction by
co-immunoprecipitation. The results are presented in
Figure 4E. As is apparent from this ﬁgure, the fraction
of HERC2 remaining associated with XPA linearly de-
creases with time over the 12h period of the experiment
even though there is no signiﬁcant change in the overall
levels of either XPA or HERC2 over this time span
(compare Figure 4D and E, top panel). Thus, it appears
Figure 4. Effect of DNA damage on the interaction of XPA and HERC2. (A) Protein levels were analyzed by immunoblotting with the indicated
antibodies. A549 cells were treated with UV or mock irradiated and then times were allowed as indicated for repair in the presence of cycloheximide
(CHX). (B) Quantitative analysis of the XPA expression from the blot shown in panel (A). Averages and standard deviations were plotted from three
independent experiments. (C) cDNA was prepared from cells allowed to repair UV damage for the indicated times and was used for PCR
ampliﬁcation of the genes indicated. (D) UV treated A549 cells were allowed to repair for the indicated times and cells were fractionated into
soluble and chromatin fractions. Equal amounts of soluble and chromatin fractions were analyzed by immunoblotting with the indicated antibodies.
H2AX was used as a chromatin loading control. (E) HERC2 interaction with XPA was analyzed by immunoprecipitation of XPA from UV treated
A549 cells followed by immunoblotting of HERC2. Average values and standard deviations from three independent experiments are shown. HERC2
levels are shown as arbitrary units (AU) with 100% deﬁned as HERC2 in XPA complexes from mock-irradiated cells.
3182 Nucleic Acids Research, 2011,Vol.39, No. 8that both the association of XPA with chromatin, as well
as the dynamic engagement of XPA with other excision
repair factors, contributes to the dissociation of XPA
from HERC2 and hence the increased stability of XPA
following DNA damage.
Effect of the circadian clock on XPA acetylation and of
XPA acetylation on excision repair activity
Recently, it was reported that XPA activity was inhibited
by acetylation at residues K63 and K67, and that
deacetylation of XPA by the NAD
+-dependent SIRT1
deacetylase was a major determinant of excision repair
activity (30). It has also been reported that the NAD
+-
synthesizing enzyme, nicotinamide phosphoribosyl-
transferase (NAMPT) is expressed in a circadian
manner (31,32) and the SIRT1 deacetylase itself
exhibits circadian rhythmicity in deacetylating the
PER2 and BMAL1 proteins (33,34). Hence, we wished
to know if XPA, as well, was subject to rhythmic acetyl-
ation/deacetylation and if this rhythmicity correlated
with the circadian rhythm of excision repair activity.
To this end, we ﬁrst analyzed the effect of the circadian
rhythm on XPA acetylation in mouse liver. As seen in
Figure 5A, XPA protein is anti-phase with CRY1 with
the XPA peak at ZT10 and the CRY1 peak at ZT22, as
reported previously (13,14). When the acetyl-XPA was
measured as a function of ZT time (ZT = 0 and 12,
light on and off, respectively, under a 12h light:12h
dark cycle) although a weak rhythmic pattern was
observed, with maximum at ZT06 and minimum at
ZT14, there was no obvious circadian pattern (Figure
5B and C). Furthermore, the rhythmic pattern was abol-
ished in CRY-null background (Figure 5B, lanes 7 and
8), indicating that the weak non-circadian rhythmicity is
controlled by the circadian clock.
When the XPA acetylation pattern was compared with
the XPA protein level and the excision repair activity,
there was an essentially linear relationship between XPA
level and excision repair rate as reported (13,14), but no
obvious relation could be discerned between the level of
acetylated-XPA and excision repair (Figure 5C). Indeed,
when we examined the fraction of acetylated-XPA (pre-
sumably inactive) over the course of a circadian cycle it
was found that at most 3–4% of XPA is acetylated at any
given time point (Figure 5B and D) and hence the pre-
sumptive activation of XPA by SIRT1 is not expected to
make a measurable contribution to the overall active XPA
level and hence excision repair activity.
Figure 5. Circadian oscillation of the acetylation of XPA. (A) Protein levels in liver cytosol and nuclear extracts were analyzed by immunoblotting
with the indicated antibodies including histone H3 (H3). (B) Acetylated proteins from mouse liver cytosol and nuclear extracts were immunopre-
cipitated using acetyl-lysine antibody and the level of XPA was analyzed by immunoblotting for XPA. (C) Quantitative analysis of the acetylated
XPA in the liver nuclear extract. Average values and standard deviations are shown from two independent experiments with two technical meas-
urements on each together with XPA protein expression and DNA excision repair activity data from a previous report (14). (D) Acetylated proteins
from mouse liver nuclear extracts were immunoprecipitated with anti-acetyl-lysine antibodies (1  IP). The immunodepleted-lysate from 1  IP was
used for second round of immunoprecipitation (2  IP). The level of acetylated XPA from each IP was analyzed and compared with the input signal
(10% of nuclear extracts used for IP) by immunoblotting for XPA.
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and that its deacetylation by SIRT1 is a major determin-
ant in the excision repair rate (30) was further tested in
tissue culture systems. Human HEK293T and A549 cell
lines were transfected with SIRT1 siRNA to reduce the
SIRT1 level to 10–30% of its control value (Figure 6A),
and then the cells were irradiated with UV and the rate of
repair of CPDs was determined by slot blot. The results
are shown in Figure 6B and C. As apparent qualitatively
from Figure 6B and from the quantitative analysis shown
in Figure 6C, downregulation of SIRT1 has no signiﬁcant
effect on the rate of repair of CPDs. Perhaps this is to be
expected because >95% of XPA is in the de-acetylated/
non-acetylated (active) form in untreated cells and poten-
tial inactivation of <5% of the total XPA protein by
acetylation in the absence of SIRT1 is not expected to
have a signiﬁcant effect on the overall rate of excision
repair.
DISCUSSION
The data in this article, along with our previous reports
(13,14), indicate that the XPA protein level in the mouse
brain and liver exhibits robust circadian rhythmicity
which is achieved by transcriptional control of the XPA
gene by the core molecular clock and at the post-
translational level by HERC2 E3 ubiquitin ligase. In
addition, in this article we present evidence indicating
that, at least in normal human ﬁbroblasts, XPA is rate
limiting in nucleotide excision repair, providing further
support that the circadian rhythmicity observed in
mouse brain and liver is caused by the circadian
rhythmicity of the XPA protein. Finally, we show that
even though XPA exhibits a weak and non-circadian
rhythmic acetylation in the mouse liver, because such a
small fraction of the protein is acetylated (inactive) at a
given time of the day, this acetylation and the
deacetylation by SIRT1 do not contribute signiﬁcantly
to the control of excision repair. We wish to brieﬂy
discuss these ﬁndings in the context of other studies
relevant to the topic.
First, whether XPA is rate limiting in excision repair has
been the subject of some debate. Some studies have
reported that XPA is rate limiting (35,36) while others
have claimed that reducing XPA levels to <10% of its
original value in WI38-VA ﬁbroblasts or increasing it
10-fold in a testis tumor cell line had no measurable
effect on the excision rate of UV photoproducts (20,37).
In our study, all cell lines tested, including two commonly
used tumor cell lines, HeLa and A549, and a normal
human ﬁbroblast line immortalized by telomerase
overexpression (NHF-1), exhibited reduced rates of CPD
repair when XPA was downregulated by siRNA regard-
less of the initial number of XPA molecules in a given cell
line. Importantly, when XPA was downregulated to 60, 10
and 4% of its original value in the NHF-1 cell line in a
controlled manner by titrating the amount of XPA siRNA
used in transfection, the rates of repair of both the (6–4)PP
and the CPD were proportionally reduced. Although the
rate of repair of CPDs was linearly correlated with the
level of XPA, the rate of (6–4)PP repair exhibited a para-
bolic relationship with the XPA level, consistent with the
well-established fact that the (6–4)PP is repaired at a 5- to
10-fold faster rate than the CPD both in vivo (23) and
Figure 6. Effect of SIRT1 on DNA excision repair. (A) Protein levels in the indicated cells transfected with the indicated siRNAs were analyzed by
immunoblotting with the indicated antibodies. (B) Residual CPD damage in genomic DNA from cells transfected with siRNA for 36h was detected
by immunoslot blotting using damage speciﬁc monoclonal antibodies. (C) Quantitative analysis of data shown in B. Average values and standard
deviations from two independent experiments with two technical repeats for each are plotted.
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between the rate of repair and the level of XPA it is
clear, however, that the repair rate of both the efﬁcient
substrate, the (6–4)PP, and the inefﬁcient substrate, the
CPD, is affected by as little as a 40% reduction in XPA
level in normal human ﬁbroblasts, suggesting that XPA is
rate limiting in normal human cells. This conclusion is
further supported by the ﬁnding that downregulation of
HERC2 E3 ligase results in  2-fold increase in XPA level
and causes a proportional increase in the rates of repair of
both CPDs and (6–4)PPs. Thus, the combination of the
data regarding the correspondence of rhythmicity of
excision repair with the rhythmicity of XPA and the
data on the effects of altering XPA levels by either XPA
siRNA or HERC2 siRNA leads us to conclude that XPA
is rate limiting in mouse tissues, including brain and liver,
and cultured human ﬁbroblasts. Finally, in further
support of this conclusion, we note that testis which
lacks a circadian clock (38) expresses XPA at a constant
level over the course of the day and in parallel with this
expression pattern excision repair activity in testis is
constant throughout the day (14). In a similar manner,
in Cry1/2 mutant mice XPA expression is derepressed
and constant over the circadian period and so is the nu-
cleotide excision repair activity in the liver and brain (14).
A second aspect of regulation of XPA level is the con-
tribution of HERC2 to XPA turnover and hence nucleo-
tide excision repair capacity. HERC2, a putative HECT
domain E3 ligase (39), was recently reported to function
as a scaffold to recruit a RING Finger E3 ligase to the
sites of double-strand breaks to aid in double-strand break
repair (27). It was reported that, while knockdown of
either HERC2 or RNF8 sensitizes cells to ionizing radi-
ation, an active site HERC2 mutant complemented
HERC2 depleted cells but an active site mutant of
RNF8 failed to complement RNF8 depleted cells for
resistance to ionizing radiation. Therefore, it was
concluded that RNF8 was the active E3 ligase within the
HERC2–RNF8 complex. In addition, a separate study
reported that RNF8 played an equally prominent role in
the cellular response to UV-induced DNA damage (28).
In light of these reports, our preliminary ﬁndings
indicating that HERC2 is the E3 ligase responsible for
ubiquitinating XPA (14) needed re-evaluation because
our in vitro ubiquitination assay was performed with
immunoprecipitated HERC2 which conceivably could
have been contaminated with RNF8. To address this
issue, we expressed the wild-type and putative active site
mutant HECT domains of HERC2, puriﬁed them and
tested them for activity. We found that the HECT
domain with the active site Cys!Ala mutation failed to
ubiquitinate XPA while the wild-type HECT domain
ubiquitinated it very efﬁciently, supporting our initial
report that HERC2 is the E3 ligase responsible for
binding and ubiquitinating XPA. Indeed, in a recent
report it was shown that HERC2 ubiquitinates BARD1-
uncoupled BRCA1 and targets it for degradation and,
importantly, the active site Cys!Ala mutation abolishes
ubiquitination of BRCA1, leading to its accumulation
(40). With these considerations, then, it is safe to
conclude that HERC2 plays a direct role both in
nucleotide excision repair through its effect on XPA and
in homologous recombination/double-strand break repair
through its effect on BRCA1.
Third, it was recently reported that XPA is acetylated
by an unknown acetyltransferase and that this acetylation
signiﬁcantly reduced XPA activity in excision repair by
interfering with the XPA–RPA interaction and possibly
with the interaction of XPA with other core excision
repair factors (30). It was also reported that SIRT1
bound to XPA and prevented its acetylation or, if XPA
were acetylated, SIRT1 deacetylated and thus activated it.
In support of this model it was reported that down-
regulation of SIRT1 signiﬁcantly reduced both the repair
rate of CPDs and the survival of UV-irradiated cells. This
report raised the interesting possibility that the circadian
rhythm of excision repair (13,14) might be generated by
the XPA acetylation/deacetylation rhythm because both
SIRT1 (33,34) and the NAD
+ synthesizing enzyme,
NAMPT (31,32) exhibit circadian rhythms. Thus, it was
conceivable that the circadian rhythms of NAD
+ and
SIRT1 would engender an acetylation–deacetylation
cycle of XPA with circadian periodicity, resulting in
daily oscillation of excision repair activity. However, our
data show that in mouse liver <5% of XPA is acetylated
at a given time of the day, which means that >95% of
XPA is active at all times and activation of <5% of XPA
is not expected to make a substantial contribution to the
rate of repair. In support of this prediction, we found that
downregulation of SIRT1 in two human cell lines did not
affect the rate of excision repair of CPDs. We have no
satisfactory explanation for the difference between our
data and the previous report (30). We note, however,
that there was no quantitative analysis of the apparently
minor difference seen in the repair data in the previous
study and that downregulation of SIRT1 affects many
cellular functions and may indirectly affect cell survival
following UV damage by affecting general cellular physi-
ology. In any event, our experiments on XPA acetylation
and repair both in mouse liver and in human cell lines
yield results consistent with the conclusion that SIRT1
deacetylation of XPA does not contribute to the circadian
rhythmicity of excision repair.
Finally, the selective advantage of circadian rhythmicity
of excision repair deserves some comment. As has been
noted previously the excision repair system is not entirely
without side effects (3,9). Biochemical evidence indicates
that both in prokaryotes and in eukaryotes nucleotide
excision repair systems attack undamaged DNA,
removing oligonucleotides free of damage (5). Based on
this ﬁnding, it was suggested that during ﬁlling of the
excision gap (gratuitous repair) errors could occur result-
ing in spontaneous mutagenesis. Indeed, recent studies in
prokaryotes have provided some support for this predic-
tion (6,7). Therefore, the levels of excision repair proteins
must be controlled within certain limits so as to be able to
eliminate DNA lesions that occur during daily wear and
tear, and upregulated when there is an increase to the
spontaneous mutation load. This ﬁne-tuning is achieved
in E. coli by increasing the transcription of the uvrA and
uvrB genes by the SOS response in response to genotoxic
stress and proteolysis of UvrA by ClpXP protease upon
Nucleic Acids Research,2011, Vol.39, No. 8 3185completion of repair (8,9). In eukaryotes, there is no
SOS-like damage response. The transcription of two
genes, XPC and XPE (DDB2), is induced by DNA
damage but the levels of these proteins either do not
change or show only a modest increase (10–12) and both
proteins are ubiquitinated by the CUL4 complex follow-
ing DNA damage. Ubiquitination leads to degradation of
DDB2; however, the role of ubiquitination of XPC is con-
troversial with some reports suggesting that it increases
the speciﬁcity of XPC for damaged DNA while others
claim that it promotes degradation by the proteasome
(12). In any event, XPE is not essential for repair and
whether it participates in repair at all is controversial
(10,12,41). Here, we show that a key protein in nucleotide
excision repair, XPA, is regulated both at transcriptional
and post-translational levels in a manner quite similar to
the regulation of UvrA, albeit the transcriptional control
of UvrA is by the SOS response while the control of XPA
transcription is by the molecular clock.
A further question is the physiological and evolutionary
relevance of the phasing of the XPA and excision repair
rhythmicity with the sleep/wake and anabolic/catabolic
rhythms of the mouse. It is difﬁcult to address this issue
with any certainty. It is generally accepted that the circa-
dian clock evolved as a mechanism to minimize DNA
damage by the high ﬂux UV present in the beginning of
evolution of eukaryotic organisms (‘escape from light’ hy-
pothesis) (42,43) and thus the clock and DNA repair
pathways are evolutionarily linked. Viewed from this per-
spective, several models can be advanced. In one model,
the phasing is an evolutionary relic with no selective ad-
vantage because mice are nocturnal animals, rarely
venture into sunlight and therefore the steady increase in
excision repair during the daytime and its decline at night
does not help mice to cope better with genotoxic stress
from chemical agents they are exposed to during their
active night phase. Alternatively, it could be argued that
even though mice are nocturnal animals they do venture
out for short periods during the day and therefore the
increased rate of repair of UV photoproducts over
the course of the day does confer a selective advantage.
Finally, it is also possible that the day phase in mice,
the anabolic phase in which reactive metabolites such
as the lipid peroxidation product malondialdehyde
are generated, attack DNA and cause mutagenic lesions
(44) and therefore increased repair rate during this phase
helps in rapid removal of potentially mutagenic legions.
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